Strategic report seeks urgent IP reforms in Australia
This article was originally published in Scrip
Executive Summary
The same week it bemoaned market conditions for pharma firms, the R&D-based industry association, Medicines Australia, has applauded a government backed report outlining a 10-year strategic health and medical research plan for Australia. The clearest call in the report is for Australia’s intellectual property system should be harmonized with international standard by extending the term of pharmaceutical data exclusivity. The report itself says its plan should be treated as an urgent national priority. And Medicines Australia agrees: CEO Brendan Shaw said the recommendations deserved bi-partisan support and that they should be implemented "expeditiously.